Virtus Investment Advisers, LLC
Top Portfolio Positions
449 positions ·
$361,568,458 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| GILD |
Gilead Sciences, Inc.
Healthcare
|
20,473 | $2,853,322 | 0.79% | |
| AMGN |
Amgen Inc
Healthcare
|
8,056 | $2,834,503 | 0.78% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
3,598 | $2,779,958 | 0.77% | |
| IBRX |
ImmunityBio, Inc.
Healthcare
|
357,747 | $2,743,919 | 0.76% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
5,869 | $2,620,743 | 0.72% | |
| INCY |
Incyte Corp
Healthcare
|
27,189 | $2,559,028 | 0.71% | |
| VRT |
Vertiv Holdings Co
Industrials
|
10,030 | $2,513,317 | 0.70% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
7,471 | $2,471,929 | 0.68% | |
| EIX |
Edison International
Utilities
|
32,966 | $2,412,451 | 0.67% | |
| ROST |
Ross Stores, Inc.
Consumer Cyclical
|
10,202 | $2,210,059 | 0.61% |
Portfolio Trend
18 quarters · across all stocks
Holdings in NGNE
Shares Held
Position Value (USD)
5 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $262,745 | 13,033 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $261,949 | 12,716 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $96,666 | 5,578 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $68,904 | 4,609 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $86,080 | 7,351 | Shares | Other | 2025-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||